Cassidy Bio
Health
· Headquartered in Israel 🇮🇱
Track Cassidy Bio
— get Health deals in free daily digest
Overview
Cassidy Bio has raised $8 million in seed funding, led by Ahren Innovation Capital, with participation from Lool Ventures and 10D VC, along with backing from AstraZeneca and Merck KGaA. The company aims to revolutionize gene-editing therapy development through its AI-driven genomic foundation model.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Ahren Innovation Capital, Lool Ventures, 10D VC, AstraZeneca, Merck KGaA
Cassidy Bio has raised $8 million in seed funding, led by Ahren Innovation Capital, with participation from Lool Ventures and 10D VC, along with backing from AstraZeneca and Merck KGaA. The company aims to revolutionize gene-editing therapy development through its AI-driven genomic foundation model.